Prime Capital Investment Advisors LLC Has $661,000 Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Prime Capital Investment Advisors LLC lessened its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 16.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 11,120 shares of the company’s stock after selling 2,128 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in DocuSign were worth $661,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Assenagon Asset Management S.A. raised its stake in DocuSign by 321.3% in the 3rd quarter. Assenagon Asset Management S.A. now owns 214,877 shares of the company’s stock worth $9,025,000 after purchasing an additional 163,875 shares in the last quarter. Executive Wealth Management LLC acquired a new stake in DocuSign in the 3rd quarter worth about $1,000,000. SG Americas Securities LLC raised its stake in DocuSign by 93.1% in the 4th quarter. SG Americas Securities LLC now owns 78,423 shares of the company’s stock worth $4,662,000 after purchasing an additional 37,801 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in DocuSign by 77.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company’s stock worth $51,057,000 after purchasing an additional 531,682 shares in the last quarter. Finally, Grimes & Company Inc. acquired a new stake in DocuSign in the 3rd quarter worth about $12,047,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Trading Down 1.5 %

Shares of DocuSign stock opened at $59.25 on Thursday. The firm has a market capitalization of $12.17 billion, a PE ratio of 164.59, a price-to-earnings-growth ratio of 5.22 and a beta of 0.89. The firm’s 50 day moving average is $55.35 and its 200 day moving average is $51.41. DocuSign, Inc. has a 1 year low of $38.11 and a 1 year high of $64.76.

DocuSign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.06. The company had revenue of $712.39 million for the quarter, compared to analyst estimates of $698.05 million. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. As a group, research analysts anticipate that DocuSign, Inc. will post 0.86 earnings per share for the current year.

Insider Activity at DocuSign

In related news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the sale, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the sale, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Allan C. Thygesen sold 7,765 shares of the business’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $53.31, for a total transaction of $413,952.15. Following the sale, the chief executive officer now directly owns 104,002 shares in the company, valued at $5,544,346.62. The disclosure for this sale can be found here. In the last three months, insiders have sold 54,871 shares of company stock valued at $3,176,199. 17.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Royal Bank of Canada reiterated a “sector perform” rating and issued a $50.00 price objective on shares of DocuSign in a research note on Friday, January 12th. TheStreet upgraded shares of DocuSign from a “d+” rating to a “c-” rating in a research report on Tuesday, December 19th. JMP Securities restated a “market outperform” rating and issued a $84.00 target price on shares of DocuSign in a research report on Monday, January 22nd. Morgan Stanley upgraded shares of DocuSign from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $49.00 to $64.00 in a research report on Tuesday, January 16th. Finally, Wells Fargo & Company dropped their target price on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research report on Monday, February 5th. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $58.33.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.